| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 756225 | GW410563A | 0.00115116014164088 | 0.3203363 |
| NSC 670678 | Glutamic acid, N-[4-[[[2-(ethoxycarbonyl)-3-quinoxalinyl] amino]phenyl]carbonyl]-, diethyl ester | 0.00118765873091044 | 0.46394678 |
| NSC 664529 | Null | 0.00126165886744893 | -0.087339955 |
| NSC 670312 | Null | 0.00126165886744893 | -0.3304292 |
| NSC 128687 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) | 0.00134950525162029 | -0.16359 |
| NSC 719362 | Null | 0.00196933781777179 | -0.24467877 |
| NSC 174121 | Methotrexate Derivative | 0.00227699677919294 | -0.30864794 |
| NSC 234214 | NSC 234214 | 0.00227699677919294 | -0.25563153 |
| NSC 632129 | (E)-1-(2,5-Dihydroxyphenyl)ethene-2-isonitrile | 0.00227699677919294 | -0.17499887 |
| NSC 666783 | Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol | 0.00227699677919294 | -0.12525865 |